MLICM
AXNX

Metropolitan Life Insurance Company (MetLife)’s Axonics, Inc. Common Stock AXNX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,615
Closed -$180K – 2235
2024
Q1 		$180K Sell
2,615
-212
-7% -$14.3K 0.01% 761
2023
Q4 		$176K Hold
2,827
– – 0.01% 794
2023
Q3 		$159K Buy
2,827
+108
+4% +$6.08K 0.01% 784
2023
Q2 		$137K Hold
2,719
– – 0.01% 863
2023
Q1 		$148K Sell
2,719
-401
-13% -$23.4K 0.01% 793
2022
Q4 		$195K Buy
3,120
+175
+6% +$11.6K 0.01% 725
2022
Q3 		$207K Buy
2,945
+163
+6% +$11.2K 0.01% 664
2022
Q2 		$158K Sell
2,782
-195
-7% -$10.7K 0.01% 818
2022
Q1 		$186K Sell
2,977
-8,782
-75% -$473K 0.01% 850
2021
Q4 		$659K Hold
11,759
– – 0.01% 1242
2021
Q3 		$765K Buy
11,759
+265
+2% +$18.1K 0.01% 1154
2021
Q2 		$729K Buy
11,494
+2,296
+25% +$136K 0.01% 1251
2021
Q1 		$551K Sell
9,198
-325
-3% -$17.7K 0.01% 1358
2020
Q4 		$475K Hold
9,523
– – 0.01% 1385
2020
Q3 		$486K Hold
9,523
– – 0.01% 1235
2020
Q2 		$334K Buy
9,523
+4,121
+76% +$142K 0.01% 1480
2020
Q1 		$137K Hold
5,402
– – ﹤0.01% 1830
2019
Q4 		$150K Hold
5,402
– – ﹤0.01% 2099
2019
Q3 		$145K Buy
5,402
+4,224
+359% +$147K ﹤0.01% 2094
2019
Q2 		$48.3K Buy
+1,178
New +$33.1K ﹤0.01% 2507

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Metropolitan Life Insurance Company (MetLife)'s AXNX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 2,615 shares — an estimated $180K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AXNX in Q2 2019 and held it in 20 quarters. The position peaked at $765K in Q3 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,615 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $180K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 20 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Axonics, Inc. Common Stock position peaked at $765K in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.